Regulation of the Chemokine Receptor CXCR4 by Ubiquitin
Regulation of the Chemokine Receptor CXCR4 by Ubiquitin
批准号:
8029591
负责人:
Adriano Marchese
金额:
$26.2万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-02-01 至 2014-01-31
关键词:
AgonistArrestinsBindingBiological AssayBone MarrowBrainCXCR4 ReceptorsCXCR4 geneCardiovascular DiseasesCell membraneCellsChemotaxisChronicClathrinCo-ImmunoprecipitationsComplexDataDegradation PathwayDiseaseDominant-Negative MutationDown-RegulationEarly EndosomeFunctional disorderG protein coupled receptor kinaseGRKGoalsHIVHeart failureHematopoietic stem cellsHomingHumanImmunofluorescence MicroscopyImmunologic Deficiency SyndromesIn VitroInterventionLigandsLinkLymphocyteLysosomesMalignant NeoplasmsMediatingModelingMolecularMonoubiquitinationMutagenesisMyocardial IschemiaPathologyPathway interactionsPhosphorylationPlayPrevention strategyProtein KinaseProteinsProteolysisRecruitment ActivityRegulationResearch PersonnelRoleSeriesSerineSignal TransductionSmall Interfering RNASorting - Cell MovementStagingStem cellsStromal CellsSyndromeTailTechniquesUbiquitinUbiquitinationcardiogenesischemokine receptorcoated pitdesensitizationinhibitor/antagonistinsightmalignant breast neoplasmmutantnon-visual arrestinsnovelprogramsreceptorresearch studyubiquitin ligaseubiquitin-protein ligase
中文摘要
描述(由申请人提供):本提案的主要目标是阐明趋化因子受体CXCR 4调节的细胞和分子机制。CXCR4失调与几种病理学有关,包括乳腺癌、HIV、WHIM综合征和心血管疾病如慢性缺血性心脏病、心绞痛和人类终末期心力衰竭。了解调节CXCR4的机制可能为预防和治疗与CXCR4失调相关的病理提供新的策略。CXCR 4在质膜上经历由E3泛素连接酶AIP 4介导的激动剂依赖性泛素化,其通过充当内体分选信号靶向受体以在溶酶体中降解。然而,对AIP4识别和泛素化活化的CXCR4及其在CXCR4信号传导中的作用的细胞和分子机制缺乏了解。我们提供的初步证据表明,AIP4与非视觉arrestins相互作用,磷酸化可能在靶向CXCR4溶酶体中发挥作用。我们假设AIP4介导的CXCR4的泛素化之前是磷酸化,导致抑制蛋白的募集,抑制蛋白作为一个适配器,反过来招募AIP4到CXCR4。我们还提供了证据表明,CXCR4上的泛素部分不仅作为内体分选信号,但也可能作为一个快速和立即终止信号在质膜。我们提出了一个全面的一系列的研究,旨在检查抑制蛋白和AIP4之间的相互作用,在细胞内和体外使用GST下拉测定,免疫共沉淀研究,siRNA分析和免疫荧光显微镜实验。我们的目标是确定细胞和分子机制,决定AIP4如何识别和泛素化激活CXCR4调节其信号。提出了以下具体目标:1。确定泛素连接酶AIP4如何识别和泛素化活化的CXCR4。2.确定磷酸化在介导AIP4依赖性泛素化和CXCR4降解中的作用。3.确定AIP4依赖性CXCR4泛素化在CXCR4介导的信号转导调节中的作用。
英文摘要
DESCRIPTION (provided by applicant): The primary goal of this proposal is to elucidate the cellular and molecular mechanisms by which the chemokine receptor CXCR4 is regulated. CXCR4 dysregulation has been associated with several pathologies including breast cancer, HIV, WHIM syndrome and cardiovascular disease sates such as chronic ischemic heart disease, angina and human end-stage heart failure. Understanding the mechanisms regulating CXCR4 may provide new strategies for the prevention and treatment of the pathologies associated with CXCR4 dysregulation. CXCR4 undergoes agonist-dependent ubiquitination at the plasma membrane mediated by the E3 ubiquitin ligase AIP4, which targets the receptor for degradation in lysosomes by serving as an endosomal sorting signal. However, insight into the cellular and molecular mechanisms by which AIP4 recognizes and ubiquitinates activated CXCR4 and its role on CXCR4 signaling is lacking. We provide initial evidence demonstrating that AIP4 interacts with non-visual arrestins and that phosphorylation may play a role in targeting CXCR4 to lysososmes. We hypothesize that AIP4-mediated ubiquitination of CXCR4 is preceded by phosphorylation leading to arrestin recruitment, which serves as an adaptor to in turn recruit AIP4 to CXCR4. We also provide evidence that suggests that the ubiquitin moiety on CXCR4 not only serves as an endosomal sorting signal, but may also serve as a rapid and immediate terminator of signaling at the plasma membrane. We propose a comprehensive series of studies aimed at examining the interaction between arrestins and AIP4 in cells and in vitro using GST pull-down assays, co- immunoprecipitation studies, siRNA analysis and immunofluorescence microscopy experiments. Our objective is to define the cellular and molecular mechanisms that determine how AIP4 recognizes and ubiquitinates activated CXCR4 to regulate its signaling. The following Specific Aims are proposed: 1. To define how the ubiquitin ligase AIP4 recognizes and ubiquitinates activated CXCR4. 2. To determine the role of phosphorylation in mediating AIP4-dependent ubiquitination and degradation of CXCR4. 3. To determine the role of AIP4-dependent CXCR4 ubiquitination on regulation of CXCR4 mediated signaling.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.cellsig.2012.11.024
发表时间:
2013-03
期刊:
Cellular signalling
影响因子:
4.8
作者:
[Marchese A, Trejo J]
通讯作者:
Trejo J
Ubiquitination of GPCRs.
GPCR 的泛素化。
DOI:
10.1007/978-1-61779-126-0_13
发表时间:
2011
期刊:
Methods in molecular biology (Clifton, N.J.)
影响因子:
--
作者:
[Caballero,Adriana, Marchese,Adriano]
通讯作者:
Marchese,Adriano
Regulation of chemokine receptor signaling
-
批准号:10622915
-
项目类别:
-
资助金额:$25.03万
-
财政年份:2023
-
负责人:Adriano Marchese
-
依托单位:
FASEB SRC: The G Protein-coupled Receptor Kinases and Arrestins Conference: Key Modulators of Signal Transduction
-
批准号:10464336
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2022
-
负责人:Adriano Marchese
-
依托单位:
Bi-directional regulation of chemokine receptor signaling
-
批准号:10795393
-
项目类别:
-
资助金额:$12.87万
-
财政年份:2021
-
负责人:Adriano Marchese
-
依托单位:
Bi-directional regulation of chemokine receptor signaling
-
批准号:10646415
-
项目类别:
-
资助金额:$30.61万
-
财政年份:2021
-
负责人:Adriano Marchese
-
依托单位:
Bi-directional regulation of chemokine receptor signaling
-
批准号:10317369
-
项目类别:
-
资助金额:$31.0万
-
财政年份:2021
-
负责人:Adriano Marchese
-
依托单位:
Bi-directional regulation of chemokine receptor signaling
-
批准号:10471999
-
项目类别:
-
资助金额:$30.61万
-
财政年份:2021
-
负责人:Adriano Marchese
-
依托单位:
Role of beta-arrestins in chemokine receptor signaling
-
批准号:10300898
-
项目类别:
-
资助金额:$1.3万
-
财政年份:2014
-
负责人:Adriano Marchese
-
依托单位:
Role of beta-arrestins in chemokine receptor signaling
-
批准号:10391496
-
项目类别:
-
资助金额:$32.05万
-
财政年份:2014
-
负责人:Adriano Marchese
-
依托单位:
Role of beta-arrestins in G protein-coupled receptor sorting and signaling
-
批准号:8877924
-
项目类别:
-
资助金额:$13.3万
-
财政年份:2014
-
负责人:Adriano Marchese
-
依托单位:
Role of beta-arrestins in chemokine receptor signaling
-
批准号:10386287
-
项目类别:
-
资助金额:$13.81万
-
财政年份:2014
-
负责人:Adriano Marchese
-
依托单位:
Role of beta-arrestins in G protein-coupled receptor sorting and signaling
-
批准号:8632561
-
项目类别:
-
资助金额:$29.08万
-
财政年份:2014
-
负责人:Adriano Marchese
-
依托单位:
Role of beta-arrestins in chemokine receptor signaling
-
批准号:10610180
-
项目类别:
-
资助金额:$6.52万
-
财政年份:2014
-
负责人:Adriano Marchese
-
依托单位:
Chemokine-mediated Modulaton of Opioid-induced Pain
-
批准号:7860385
-
项目类别:
-
资助金额:$29.4万
-
财政年份:2008
-
负责人:Adriano Marchese
-
依托单位:
Chemokine-mediated Modulaton of Opioid-induced Pain
-
批准号:8082785
-
项目类别:
-
资助金额:$28.52万
-
财政年份:2008
-
负责人:Adriano Marchese
-
依托单位:
Chemokine-mediated Modulaton of Opioid-induced Pain
-
批准号:7686942
-
项目类别:
-
资助金额:$29.7万
-
财政年份:2008
-
负责人:Adriano Marchese
-
依托单位:
Chemokine-mediated Modulaton of Opioid-induced Pain
-
批准号:7587873
-
项目类别:
-
资助金额:$29.7万
-
财政年份:2008
-
负责人:Adriano Marchese
-
依托单位:
Chemokine-mediated Modulaton of Opioid-induced Pain
-
批准号:8267066
-
项目类别:
-
资助金额:$28.52万
-
财政年份:2008
-
负责人:Adriano Marchese
-
依托单位:
Regulation of the Chemokine Receptor CXCR4 by Ubiquitin
-
批准号:7348362
-
项目类别:
-
资助金额:$26.73万
-
财政年份:2007
-
负责人:Adriano Marchese
-
依托单位:
Regulation of the Chemokine Receptor CXCR4 by Ubiquitin
-
批准号:7197236
-
项目类别:
-
资助金额:$26.73万
-
财政年份:2007
-
负责人:Adriano Marchese
-
依托单位:
Regulation of the Chemokine Receptor CXCR4 by Ubiquitin
-
批准号:7578864
-
项目类别:
-
资助金额:$26.73万
-
财政年份:2007
-
负责人:Adriano Marchese
-
依托单位:
国内基金
海外基金
登录
查看更多内容
AT1R-G蛋白/β-arrestins通路偏好性激活在急性肾损伤中的作用及其机制
-
批准号:82104272
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:贾英丽
-
依托单位:
催产素受体Gαq与β-arrestins偏爱型信号通路在产后抑郁症中的作用
-
批准号:82104148
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:朱佳蕾
-
依托单位:
β-arrestins在DC细胞迁移及自身免疫疾病中的作用及机制研究
-
批准号:31871404
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2018
-
负责人:杜昌升
-
依托单位:
β-arrestins调节小胶质细胞M1/M2表型转化及其在阿尔兹海默病进程中的作用
-
批准号:81703488
-
项目类别:青年科学基金项目
-
资助金额:20.1万元
-
批准年份:2017
-
负责人:方吟荃
-
依托单位:
β-arrestins保护心肌梗死的作用和机制研究
-
批准号:81670260
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2016
-
负责人:刘冲
-
依托单位:
beta-arrestins在自感光神经节细胞光信号转导中的作用和机制研究
-
批准号:31601134
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2016
-
负责人:赵欢
-
依托单位:
支气管上皮细胞恶性转化中β-arrestins的作用及其机制研究
-
批准号:81301728
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:申洪昌
-
依托单位:
β-arrestins通过ER stress/Puma调控门脉高压性胃病的机制
-
批准号:81370511
-
项目类别:面上项目
-
资助金额:75.0万元
-
批准年份:2013
-
负责人:吴斌
-
依托单位:
β-arrestins介导甘丙肽2型受体信号转导的作用机理及其可能的抗抑郁机制
-
批准号:31171032
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:徐志卿
-
依托单位:
β-arrestins在缺血再灌注性肝损伤及其修复中的作用和机制
-
批准号:81170422
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:汪根树
-
依托单位: